We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

35 hedge funds and large institutions have $47.1M invested in Global Cord Blood Corporation in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

12% more capital invested

Capital invested by funds: $42M → $47.1M (+$5.18M)

3% less funds holding

Funds holding: 3635 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
13
Reduced
4
Closed
8
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q4 2015 in Review

35 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2015, worth a combined $47.1M — up 12% from $42M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CO and 7 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 13 added.

The largest buyer was GLG Partners, adding an estimated $3.55M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $2.44M sold.

  • 35 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2015, down from 36 in Q3 2015.
  • Funds reported $47.1M of Global Cord Blood Corporation stock for Q4 2015, up 12% quarter-over-quarter.
  • 7 funds opened new Global Cord Blood Corporation positions in Q4 2015 and 8 closed out, a net change of -1 holder.
  • The largest Global Cord Blood Corporation buyer in Q4 2015 was GLG Partners, an estimated $3.55M added.
  • The largest Global Cord Blood Corporation seller in Q4 2015 was Farallon Capital Management, an estimated $2.44M sold.

Based on aggregated 13F filings for Q4 2015.